Timing of surgery in breast cancer
- 1 June 1991
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 337 (8757) , 1603-1605
- https://doi.org/10.1016/0140-6736(91)93298-n
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Effect of Tamoxifen on Serum Insulinlike Growth Factor I Levels in Stage I Breast Cancer PatientsJNCI Journal of the National Cancer Institute, 1990
- Menstrual status and breast cancer surgeryBreast Cancer Research and Treatment, 1990
- Uterine Insulin-Like Growth Factor-1: Regulation of Expression and Its Role in Estrogen-Induced Uterine Proliferation*Endocrine Reviews, 1990
- MENSTRUAL EFFECT ON SURGICAL CURE OF BREAST CANCERThe Lancet, 1989
- Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.Journal of Clinical Investigation, 1989
- MENSTRUAL INFLUENCE ON SURGICAL CURE OF BREAST CANCERThe Lancet, 1989
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Variation in natural killer activity in peripheral blood during the menstrual cycle.BMJ, 1985
- Mitotic Activity in the BreastJournal of Obstetrics and Gynaecology, 1984
- Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast diseaseBritish Journal of Cancer, 1982